Volume 60, Issue 6, Pages (December 2001)

Slides:



Advertisements
Similar presentations
Volume 65, Issue 5, Pages (May 2004)
Advertisements

Benefits of switching from a conventional to a low-GDP bicarbonate/lactate-buffered dialysis solution in a rat model  Siska Mortier, Dirk Faict, Norbert.
Volume 68, Issue 4, Pages (October 2005)
Volume 57, Issue 2, Pages (October 2000)
l-Carnitine is an osmotic agent suitable for peritoneal dialysis
Volume 66, Issue 6, Pages (December 2004)
Volume 65, Issue 1, Pages (January 2004)
l-Carnitine is an osmotic agent suitable for peritoneal dialysis
Volume 67, Issue 5, Pages (May 2005)
Wei Zhou, MD, Hong Chai, MD, PhD, Andy Courson, BS, Peter H
Cyril H. Barton, Zehnmin Ni, Nosratola D. Vaziri  Kidney International 
Volume 64, Issue 1, Pages (July 2003)
Volume 69, Issue 4, Pages (February 2006)
Use of icodextrin in high transport ultrafiltration failure
D. Teta, M. Maillard, G. Halabi, M. Burnier  Kidney International 
Volume 62, Issue 2, Pages (August 2002)
Y.-H.H. Lien, K.-C. Yong, C. Cho, S. Igarashi, L.-W. Lai 
Volume 82, Issue 11, Pages (December 2012)
Volume 71, Issue 3, Pages (February 2007)
Volume 56, Issue 6, Pages (December 1999)
Smad7 gene transfer inhibits peritoneal fibrosis
Volume 68, Issue 6, Pages (December 2005)
l-Carnitine is an osmotic agent suitable for peritoneal dialysis
Volume 68, Issue 2, Pages (August 2005)
Volume 83, Issue 5, Pages (May 2013)
Volume 66, Issue 6, Pages (December 2004)
Volume 69, Issue 10, Pages (May 2006)
Water transport across the peritoneal membrane
Volume 62, Issue 2, Pages (August 2002)
Volume 62, Issue 4, Pages (October 2002)
Volume 57, Issue 2, Pages (October 2000)
Volume 59, Issue 3, Pages (March 2001)
Volume 56, Issue 6, Pages (December 1999)
Volume 60, Issue 4, Pages (October 2001)
Volume 69, Issue 1, Pages (January 2006)
Volume 80, Issue 4, Pages (August 2011)
Volume 68, Issue 5, Pages (November 2005)
Volume 68, Issue 4, Pages (October 2005)
Volume 60, Issue 5, Pages (November 2001)
PPARα agonist fenofibrate improves diabetic nephropathy in db/db mice
Volume 61, Issue 1, Pages (January 2002)
Volume 86, Issue 6, Pages (December 2014)
Volume 65, Issue 1, Pages (January 2004)
The effects of ginsenoside Rb1 on endothelial damage and ghrelin expression induced by hyperhomocysteine  Zhiwei Xu, PhD, Taohua Lan, MD, Weikang Wu,
Volume 61, Issue 6, Pages (June 2002)
Pharmacologic relaxation of vein grafts is beneficial compared with pressure distention caused by upregulation of endothelial nitric oxide synthase and.
Volume 58, Issue 6, Pages (December 2000)
Benefits of switching from a conventional to a low-GDP bicarbonate/lactate-buffered dialysis solution in a rat model  Siska Mortier, Dirk Faict, Norbert.
Volume 66, Issue 3, Pages (September 2004)
Volume 61, Issue 6, Pages (June 2002)
Volume 54, Issue 5, Pages (November 1998)
Volume 64, Issue 5, Pages (November 2003)
Volume 85, Issue 1, Pages (January 2014)
Rosiglitazone reverses tenofovir-induced nephrotoxicity
Circulating endothelial nitric oxide synthase inhibitory factor in some patients with chronic renal disease  Shen Xiao, Laszlo Wagner, Rebecca J. Schmidt,
Volume 60, Issue 1, Pages (July 2001)
Volume 60, Issue 3, Pages (September 2001)
Volume 62, Issue 1, Pages (July 2002)
Volume 61, Issue 2, Pages (February 2002)
Volume 60, Issue 2, Pages (August 2001)
Volume 84, Issue 2, Pages (August 2013)
Prasun K. Datta, Elias A. Lianos  Kidney International 
Effects of mifepristone on expression of endothelial nitric oxide synthase in human endometrium during the implantation phase  Xiaoxi Sun, M.D., Xiaoyan.
Volume 64, Issue 1, Pages (July 2003)
Volume 57, Issue 2, Pages (October 2000)
Volume 65, Issue 1, Pages (January 2004)
A sphingosine-1-phosphate type 1 receptor agonist inhibits the early T-cell transient following renal ischemia–reperfusion injury  L.-W. Lai, K.-C. Yong,
Volume 61, Issue 3, Pages (March 2002)
Volume 57, Issue 1, Pages (January 2000)
Matrix Metalloproteinase Inhibitor BB-3103 Unlike the Serine Proteinase Inhibitor Aprotinin Abrogates Epidermal Healing of Human Skin Wounds Ex Vivo1 
Presentation transcript:

Volume 60, Issue 6, Pages 2343-2350 (December 2001) Inhibition of nitric oxide synthase reverses changes in peritoneal permeability in a rat model of acute peritonitis  Marie-Laure Ferrier, Sophie Combet, Mieke Van Landschoot, Maria S. Stoenoiu, Yvette Cnops, Norbert Lameire, Olivier Devuyst  Kidney International  Volume 60, Issue 6, Pages 2343-2350 (December 2001) DOI: 10.1046/j.1523-1755.2001.00050.x Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 1 Effects of acute peritonitis on the peritoneum: Morphology and immunostaining. Hemalun-eosine staining (A and B) and immunostaining for eNOS (C and D) in the visceral peritoneum of control rats (A-C) and rats with acute peritonitis (B-E). A marked edema and a massive infiltrate of mononuclear cells characterize the peritoneum of rats with peritonitis (B). Immunoreactivity for endothelial nitric oxide synthase (eNOS) is located in the endothelium lining peritoneal blood vessels in control rats (C). The staining intensity and the density of capillaries and blood vessels stained for eNOS are markedly increased in rats with peritonitis (D). The staining pattern for eNOS is not modified when rats with peritonitis are treated with 5 mmol/L L-NAME in the dialysate (E). The specificity of the immunostaining for eNOS is demonstrated by the lack of signal when incubation is performed with control mouse IgG (F). Representative sections of the visceral peritoneum of control rats (G) and rats with peritonitis (H) stained for S-nitrosocysteine. A major increase in the immunoreactivity is observed in rats with peritonitis, particularly located in the mesothelial and endothelial cell layers. The inset demonstrates the intense immunoreactivity for S-nitrosocysteine in the endothelium lining peritoneal capillaries. A similar staining pattern for S-nitrosocysteine is observed in the peritoneum of peritonitis rats that have been treated with L-NAME (I) (original magnification A-H, ×350; inset, ×485; I, ×380). Kidney International 2001 60, 2343-2350DOI: (10.1046/j.1523-1755.2001.00050.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 2 Effects of acute peritonitis on NOS expression and activity in the peritoneum. (A) Immunoblot analysis for endothelial (eNOS) and inducible (iNOS) nitric oxide synthase in peritoneum extracts prepared from control rats and rats with acute peritonitis (40 μg protein/lane, 6 samples in each group). Extracts from bovine aortic endothelial cells (eNOS) and mouse macrophages (iNOS) were used as positive controls (lane C). A consistent up-regulation of eNOS (140 kD) is detected in samples from rats with acute peritonitis. The signal for iNOS (130 kD, lower band of the blot), never detected in control samples, is up-regulated with variable intensity in rats with acute peritonitis. Note that the monoclonal antibody against iNOS cross-reacts with eNOS (middle band at 140 kD) and nNOS (upper band at 155 kD), as previously reported12. (B) NOS enzymatic activities in the peritoneum of control rats (C) and rats with acute peritonitis (P). Total NOS activity (▪, in pmol citrulline/mg protein/min) was assayed by the conversion of L-[3H]-arginine to L-[3H]-citrulline in the visceral peritoneum. Assays were performed with or without Ca2+, to distinguish between Ca2+-dependent () and Ca2+-independent (□) NOS activities. Total NOS activity is increased (∼3-fold) in rats with peritonitis. The increased NOS activity results from both Ca2+-dependent and Ca2+-independent NOS. *P < 0.05 between peritonitis and control rats. Kidney International 2001 60, 2343-2350DOI: (10.1046/j.1523-1755.2001.00050.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 3 Effect of L-NAME on functional parameters of peritoneal dialysis in control and peritonitis rats. The dialysate-to-plasma (D/P) ratio of urea (A) and sodium (C), and the progressive removal of glucose from the dialysate (D/D0, B) were determined in control rats (□, ▵), and rats with peritonitis (▪, ▴) during a two-hour exchange with 15 mL of 7% glucose supplemented (▵, ▴) or not (□, ▪) with 5 mmol/L L-NAME. All parameters were obtained for 6 rats in each group. Acute peritonitis induces a significant increase in permeability for urea and glucose, and a loss of sodium sieving (*P < 0.05 vs. C). These modifications are significantly reduced when L-NAME is added to the dialysate (#P < 0.05 vs. P). Kidney International 2001 60, 2343-2350DOI: (10.1046/j.1523-1755.2001.00050.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 4 Effects of acute peritonitis and addition of L-NAME in the dialysate on ultrafiltration (A), protein loss (B), and urea permeability (C) during peritoneal dialysis in rats. (A) Net ultrafiltration (volume out - volume in, in mL). (B) Total protein concentration in the dialysate (in g/L). (C) Cumulative urea permeability during the dwell (area under the curve for the 120 min-dwell, in min) in control rats (C, □) and rats with acute peritonitis (P), untreated (▪) or treated () with different doses of L-NAME (2.5, 5 and 10 mmol/L) in the dialysate (*P < 0.05 vs. C; #P < 0.05 vs. P). Kidney International 2001 60, 2343-2350DOI: (10.1046/j.1523-1755.2001.00050.x) Copyright © 2001 International Society of Nephrology Terms and Conditions